SIRT4 and liver cancer: found that SIRT4 is generally low expressed in tumor-associated macrophages of liver cancer, and down-regulation of SIRT4 can enhance fatty acid oxidation of macrophages through the FAO-PPARδ-STAT3 axis, resulting in more transformation of macrophages into The M2 subtype.